Clinical Trial Update: Screening to Improve Survival in AL Amyloidosis

View source ↗

Summary

The clinical trial update reports completion of a screening-based study aimed at improving survival in light-chain (AL) amyloidosis. The study includes particip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Light-chain Amyloidosis
• Monoclonal Gammopathy of Undetermined Significance
• Smoldering Multiple Myeloma

Snippet

Sponsor: Tufts Medical Center | Conditions: Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance | Status: COMPLETED